23-0121-European-BioTechnology-10_2-Product-Information-Ad-960x540_P2.jpg

Cell Culture Grade AB Serum that can be customised to your specifications.

© MikeMareen

Dyadic International Inc. and bYoRNA SAS partnered to advance innovative bioproduction technologies for scaling up the production of therapeutic mRNA from C1-Cells.

Stock markets love investment concepts, calling the robust ones ‘megatrends’. Golden ageing is one such megatrend banking on the fact that business can extract more from people living longer. Such megatrend investments help  – up to the moment when rising interest rates crash the party.

Picture: © AlphaValue, Paris

Stock markets love investment concepts, calling the robust ones ‘megatrends’. Golden ageing is one such megatrend banking on the fact that business can extract more from people living longer. Such megatrend investments help  – up to the moment when rising interest rates crash the party.

Fluorescence microscopy in the new Centre for Radiopharmaceutical Tumour Research of Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Picture: Frank Bierstedt/HZDR

Individually customised therapies for every patient this is the vision of the future which numerous companies, research institutions, and clusters focusing on precision medicine in Saxony are working along the entire value creation chain. They are primarily active in oncology and have gained national and international acclaim and renown both in highly specialised cancer diagnostics and innovative treatment methods.

@freepik

Biotech company, specialising in cell necrosis prevention, has announced a successful funding round, securing €1.2m in additional seed funding.

© BIOCOM

With more than 2,100 attendents, 4,700 partnering meetings so far, BioSpain 2023 is set to break records.

© catalin - stock.adobe.com

Pierre Fabre Laboratories, a leading French medical and beauty care company and Vernalis (R&D) Ltd, a fully owned subsidiary of HitGen Inc. and a specialist in drug discovery announce a long-term partnership for oncology drug discovery.

Picture: ©BioLizard

Depending on who you talk to, artificial intelligence (AI) is either a saviour or an enslaver. The concerns range from loss of jobs through to robots running society. However, in the life sciences, the use of AI and machine learning (ML) have created some excitement over their potential applications.

Ion Arocena; General Manager Asebio; © Asebio

Biotechnology is helping us tackle challenges such as emerging diseases, the impact of ageing in healthcare, population growth, climate change, and the green transition of the economy. Precision medicines, advanced therapies, mRNA and gene editing technologies are transforming the way diseases can be diagnosed and treated, providing life-saving solutions. Biotechnology is also at the forefront of building a sustainable economy, developing better crops, providing new protein sources, and producing bio-based materials.